10x Genomics CTO expects AI to leave some of biomedical R&D ‘painfully slow’ while other parts are ‘massively accelerated’
10x Genomics CTO Michael Schnall-Levin expects AI to leave parts of biomedical R&D painfully slow, with lab automation still 'extremely niche.'